Mind Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Mind Medicine
MNMD Stock  USD 14.03  0.52  3.85%   
Mind Medicine's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Mind Medicine's valuation are provided below:
Market Capitalization
1.4 B
Earnings Share
(1.98)
There are over one hundred nineteen available fundamental ratios for Mind Medicine, which can be analyzed over time and compared to other ratios. Investors should ensure to check all of Mind Medicine's last-minute performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. As of January 8, 2026, Market Cap is expected to decline to about 89.2 M. In addition to that, Enterprise Value is expected to decline to about 47.9 M
Check Mind Medicine financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mind Medicine's main balance sheet or income statement drivers, such as Depreciation And Amortization of 575.7 K, Other Operating Expenses of 125.5 M or Total Operating Expenses of 124.8 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.79. Mind financial statements analysis is a perfect complement when working with Mind Medicine Valuation or Volatility modules.
  
Build AI portfolio with Mind Stock
Check out the analysis of Mind Medicine Correlation against competitors.
For information on how to trade Mind Stock refer to our How to Trade Mind Stock guide.

Mind Medicine Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets364.8 M347.5 M92.2 M
Slightly volatile
Other Current Liabilities44.5 M42.4 M10.3 M
Slightly volatile
Total Current Liabilities46.9 M44.7 M11.4 M
Slightly volatile
Total Stockholder Equity291.5 M277.7 M75.3 M
Slightly volatile
Cash330.5 M314.8 M80.9 M
Slightly volatile
Non Currrent Assets Other1 M705 K579.4 K
Pretty Stable
Other Assets1.091.1577.9 K
Slightly volatile
Cash And Short Term Investments330.5 M314.8 M81 M
Slightly volatile
Net Receivables6.3 K5.8 K4 K
Slightly volatile
Common Stock Shares Outstanding850.8 M810.3 M146 M
Slightly volatile
Short Term Investments2 M1.9 M1.1 M
Slightly volatile
Liabilities And Stockholders Equity364.8 M347.5 M92.2 M
Slightly volatile
Other Current Assets9.5 M9.1 M2.5 M
Slightly volatile
Other Stockholder Equity772.2 M735.4 M192.4 M
Slightly volatile
Total Liabilities73.3 M69.8 M16.9 M
Slightly volatile
Total Current Assets340.1 M323.9 M83.6 M
Slightly volatile
Common Stock127.5 M121.4 M46.9 M
Slightly volatile
Short and Long Term Debt Total26.4 M25.1 M5.2 M
Slightly volatile
Property Plant And Equipment Net53.8 K57.5 K66 K
Slightly volatile
Short Term Debt48.3 K82.8 K44.8 K
Slightly volatile
Net Tangible Assets91.5 M146.4 M51.1 M
Slightly volatile
Accounts Payable2.9 M2.3 M1.8 M
Slightly volatile
Intangible Assets450.6 K474.3 K4.1 M
Slightly volatile
Other Liabilities1.5 M1.1 M2.2 M
Slightly volatile
Non Current Liabilities Total26.4 M25.1 M7 M
Slightly volatile
Capital Surpluse233 M396.5 M116.3 M
Slightly volatile
Net Invested Capital161.5 M302.8 M115.1 M
Slightly volatile
Net Working Capital142.5 M279.2 M109.1 M
Slightly volatile
Non Current Liabilities Other27.4 K28.8 K1.4 M
Slightly volatile
Long Term Debt19.8 M25.1 M15.6 M
Slightly volatile

Mind Medicine Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization575.7 K606 K672.6 K
Slightly volatile
Other Operating Expenses125.5 M119.5 M37.6 M
Slightly volatile
Total Operating Expenses124.8 M118.9 M37.3 M
Slightly volatile
Interest Income14 M13.3 M3.3 M
Slightly volatile
Selling General Administrative25.7 M44.4 M15.7 M
Slightly volatile
Cost Of Revenue575.7 K606 K787.2 K
Slightly volatile
Research Development44.8 M75.1 M30 M
Slightly volatile
Reconciled Depreciation450.6 K474.3 K1.3 M
Pretty Stable

Mind Medicine Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow120.4 M114.7 M41 M
Slightly volatile
End Period Cash Flow330.5 M314.8 M80.9 M
Slightly volatile
Sale Purchase Of Stock48.1 M70.1 M31.5 M
Slightly volatile
Depreciation575.7 K606 K663.2 K
Slightly volatile
Change To Netincome6.2 M6.6 M10.3 M
Very volatile
Change To Inventory10.4 K11.7 K12.8 K
Slightly volatile
Stock Based Compensation15.4 M15.2 M11.8 M
Slightly volatile
Issuance Of Capital Stock301.9 M287.5 M103.6 M
Slightly volatile
Cash And Cash Equivalents Changes7.6 M8 M39.7 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
PTB Ratio1.791.832.3827
Pretty Stable
Book Value Per Share6.533.945.2086
Very volatile
Invested Capital173.3 K228.9 K225.9 K
Slightly volatile
Capex To Depreciation51.2453.93196
Slightly volatile
PB Ratio1.791.832.3827
Pretty Stable
Payables Turnover0.560.30.6956
Slightly volatile
Cash Per Share2.533.53.0271
Slightly volatile
Days Payables Outstanding7481.3 K593
Slightly volatile
Net Current Asset Value147.7 K171.4 K183.4 K
Pretty Stable
Income Quality0.460.660.5599
Slightly volatile
Tangible Asset Value3.3 M3.2 M2.5 M
Slightly volatile
Intangibles To Total Assets0.140.07580.1497
Slightly volatile
Current Ratio16.128.3417.513
Slightly volatile
Tangible Book Value Per Share6.263.625.024
Very volatile
Shareholders Equity Per Share6.533.945.2086
Very volatile
Debt To Equity0.05520.08150.0258
Slightly volatile
Capex Per Share0.90.951.2777
Very volatile
Average Receivables2.8 K2.9 K3.5 K
Very volatile
Interest Debt Per Share0.320.310.1114
Slightly volatile
Debt To Assets0.0380.06510.0188
Slightly volatile
Price Book Value Ratio1.791.832.3827
Pretty Stable
Days Of Payables Outstanding7481.3 K593
Slightly volatile
Ebt Per Ebit1.311.21.14
Very volatile
Effective Tax Rate0.01160.01110.0057
Slightly volatile
Company Equity Multiplier0.941.131.1231
Pretty Stable
Long Term Debt To Capitalization0.130.09540.1443
Slightly volatile
Total Debt To Capitalization0.04810.07470.0229
Slightly volatile
Debt Equity Ratio0.05520.08150.0258
Slightly volatile
Quick Ratio16.128.3417.513
Slightly volatile
Net Income Per E B T1.11.141.0144
Slightly volatile
Cash Ratio6.186.346.9923
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio3.112.882.5286
Slightly volatile
Price To Book Ratio1.791.832.3827
Pretty Stable
Debt Ratio0.0380.06510.0188
Slightly volatile
Price Fair Value1.791.832.3827
Pretty Stable

Mind Medicine Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap89.2 M129 M133.9 M
Slightly volatile
Working Capital147.7 K171.4 K183.4 K
Pretty Stable

Mind Fundamental Market Drivers

Mind Upcoming Events

14th of March 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
14th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Mind Medicine Financial Statements

Mind Medicine stakeholders use historical fundamental indicators, such as Mind Medicine's revenue or net income, to determine how well the company is positioned to perform in the future. Although Mind Medicine investors may analyze each financial statement separately, they are all interrelated. For example, changes in Mind Medicine's assets and liabilities are reflected in the revenues and expenses on Mind Medicine's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Mind Medicine. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue606 K575.7 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
JBLJabil Circuit
MRKMerck Company
AMGNAmgen Inc
When determining whether Mind Medicine is a strong investment it is important to analyze Mind Medicine's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mind Medicine's future performance. For an informed investment choice regarding Mind Stock, refer to the following important reports:
How To Invest In Mind
Details
Is Mind Stock a good investment?
Details
What is Mind Medicine's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Mind Medicine Correlation against competitors.
For information on how to trade Mind Stock refer to our How to Trade Mind Stock guide.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mind Medicine. If investors know Mind will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mind Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.98)
Return On Assets
(0.34)
Return On Equity
(0.86)
The market value of Mind Medicine is measured differently than its book value, which is the value of Mind that is recorded on the company's balance sheet. Investors also form their own opinion of Mind Medicine's value that differs from its market value or its book value, called intrinsic value, which is Mind Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mind Medicine's market value can be influenced by many factors that don't directly affect Mind Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Mind Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mind Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mind Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY